Discussion: “With oral medications, any oral medication, I try to get older kids to time it with something they do every day. If it's a medication we'd like them to take with food well then always pair it with breakfast or dinner or something that they won't forget.”

Conclusion: Most new therapeutic options are aimed at inhibiting the inflammatory pathway and thereby improving the function of the epidermal barrier. Moreover, research is indicating that improved emollients will also be a part of the future treatment options for AD patients.

Conclusion: Children with moderate AD have impaired sleep quality and lower melatonin levels compared to controls. No correlation was found between melatonin levels and CSHQ, as well as melatonin levels and SCORAD, although there was a strong and significant correlation between SCORAD and CSHQ. Therefore, melatonin levels may not be the main...

The current results showed a considerable number of patients with AD in older age groups, and since there have been indications of a shift of AD burden to older age, the current results are important in understanding the age-related distribution in primary care.

Conclusion: Research areas that could benefit from the application of data-driven methods include the study of the pathogenesis of the condition and related risk factors, its disaggregation into validated subtypes, and personalised severity management and prognosis. We highlight BS as a new and promising approach in AD and eczema research.